| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $15.8M | -16.3% | +12.9% |
| SG&A Expense | $18.6M | -12.1% | +4.7% |
| Operating Income | $1.2M | +136.1% | +228.6% |
| Pre-tax Income | $65K | +101.2% | +102.3% |
| Income Tax | $85K | +11.8% | +11.8% |
| Net Income | -$19K | +99.7% | +99.4% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.7M | -2.0% | -27.4% |
| Accounts Receivable | $29.8M | -5.2% | +22.2% |
| Inventory | $53.1M | -2.5% | +45.4% |
| Current Assets | $167.1M | -0.8% | +18.9% |
| Total Assets | $215.2M | +1.0% | +13.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Capital Expenditures | $2.4M | — | — |
| Investing Cash Flow | -$4.8M | — | — |
| Financing Cash Flow | $1.3M | — | — |
| Free Cash Flow | -$3.8M | — | — |
| +100.0% |
| +100.0% |
| EPS (Diluted) | $0.00 | +100.0% | +100.0% |
| $88.4M |
| +4.8% |
| +62.7% |
| Total Liabilities | $153.0M | -2.5% | +13.1% |
| Stockholders' Equity | $61.5M | +10.9% | +14.9% |